Dismal is correct. They need to stop slashing R&D every time they need to save a few dollars. They were just recovering from the 2016 slash and burn.
That’s why GG orchestrated buying Bayer so We can go OTC and go direct and have Elanco lay-off wave, then Bayer lay-off wave year later, welcome to 0-1-3-5 “job protection” with 0 being US Elanco, we treat our people with “respect”
Ok, This one is confusing. Since you must be “in the know”, maybe you can explain. 1) Who is GG? 2) Elanco has to many RX brands to go all OTC, and why would they want to when acquiring an OTC line. Makes more sense to just have split businesses and portfolios. 3) If Elanco were to go direct it would require an increase in people or at minimum a hold at current level. 4)0-1-3-5?
